Quick Answer
Replimune Group, Inc. reported Common Stock Shares Outstanding of 77.09 million shares for the year ending 2025.
- Replimune Group, Inc. showed an increase of +25.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Replimune Group, Inc.'s annual report (Form 10-K), filed with the SEC on May 22, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: 5.01 million shares | Q3 2018: 31.55 million shares | Q4 2018: 31.64 million shares | Q2 2019: 31.66 million shares | Q3 2019: 31.72 million shares | Q4 2019: 36.65 million shares | Q2 2020: 40.28 million shares | Q3 2020: 40.31 million shares | Q4 2020: 46.38 million shares | Q2 2021: 46.73 million shares | Q3 2021: 46.86 million shares | Q4 2021: 47.21 million shares | Q2 2022: 49.30 million shares | Q3 2022: 49.74 million shares | Q4 2022: 56.63 million shares | Q2 2023: 58.98 million shares | Q3 2023: 59.06 million shares | Q4 2023: 61.39 million shares | Q2 2024: 68.31 million shares | Q3 2024: 68.39 million shares | Q4 2024: 77.01 million shares | Q1 2025: 77.09 million shares | Q2 2025: 77.81 million shares | Q3 2025: 78.40 million shares | Q4 2025: 79.63 million shares.
- Over the full 8 years of available data (2018 to 2025), Replimune Group, Inc.'s Common Stock Shares Outstanding has grown by 1,439.4%.
- Historical annual values: Fiscal year 2025: 77.09 million shares | Fiscal year 2024: 61.42 million shares | Fiscal year 2023: 56.68 million shares | Fiscal year 2022: 47.34 million shares | Fiscal year 2021: 46.57 million shares | Fiscal year 2020: 36.67 million shares | Fiscal year 2019: 31.66 million shares | Fiscal year 2018: 5.01 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: